Annals of the Rheumatic Diseases | ARD is an international peer-reviewed journal covering all aspects of rheumatology, including musculoskeletal conditions, arthritic disease and connective tissue disorders.

Intro Widget

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.

ARD is an official journal of EULAR.

Free lay summaries are provided for selected research articles. You can keep up with the latest news via Twitter and Facebook.

Editor-in-Chief: Professor Josef Smolen, University of Vienna, Austria
Editorial team

Impact Factor: 12.350

Authors

Annals of the Rheumatic Diseases considers unsolicited submissions of a variety of article types, including original research articles (extended and concise reports), viewpoints, and letters to the Editor.

The Author Information section provides general guidelines and requirements for specific article types.

Information is also provided on editorial policies and open access.

Impact Factor: 12.350

Author information

Submit a paper

Intro Widget

Latest Articles

Correspondence response:

Response to: ‘Can we further SPARkle the SPAR model?’ by Kavadichanda et al

Correspondence:

Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?

Letter:

Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications

Clinical and epidemiological research:

Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status

Basic and translational research:

Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency

Altmetrics

Related Journals

Most Read Articles

Recommendation:

2018 update of the EULAR recommendations for the management of Behçet’s syndrome

Recommendation:

EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis

Clinical and epidemiological research:

Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study)

Recommendation:

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

Basic and translational research:

Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis

Authors